Citations

Showing 10 of 108104 citations.

Role of adipose tissue grafting and adipose-derived stem cells in peripheral nerve surgery
Saffari, Tiam M., Saffari, TiamM, Vyas, Krishna S., Shin, Alexander Y. , Vyas, Krishna S. , Saffari, Sara , Shin, Alexander Y , Saffari, Tiam M., Vyas, Krishna S., Mardini, Samir

Mayo Clinic

Neural Regeneration Research | March 22, 2022 | Volume: 17 | Issue: 10 | Pages: 2179-2184

10.4103/1673-5374.336870 | PMID 35259826 Get It

The application of autologous fat grafting in reconstructive surgery is commonly used to improve functional form. This review aims to provide an overview of the scientific evidence on the biology of adipose tissue, the role of adipose-derived stem cells, and the indications of adipose tissue grafting in peripheral nerve surgery. Adipose tissue is easily accessible through the lower abdomen and inner thighs. Non-vascularized adipose tissue grafting does not support oxidative and ischemic stress, resulting in variable survival of adipocytes within the first 24 hours. Enrichment of adipose tissue with a stromal vascular fraction is purported to increase the number of adipose-derived stem cells and is postulated to augment the long-term stability of adipose tissue grafts. Basic science nerve research suggests an increase in nerve regeneration and nerve revascularization, and a decrease in nerve fibrosis after the addition of adipose-derived stem cells or adipose tissue. In clinical studies, the use of autologous lipofilling is mostly applied to secondary carpal tunnel release revisions with promising results. Since the use of adipose-derived stem cells in peripheral nerve reconstruction is relatively new, more studies are needed to explore safety and long-term effects on peripheral nerve regeneration. The Food and Drug Administration stipulates that adipose-derived stem cell transplantation should be minimally manipulated, enzyme-free, and used in the same surgical procedure, e.g. adipose tissue grafts that contain native adipose-derived stem cells or stromal vascular fraction. Future research may be shifted towards the use of tissue-engineered adipose tissue to create a supportive microenvironment for autologous graft survival. Shelf-ready alternatives could be enhanced with adipose-derived stem cells or growth factors and eliminate the need for adipose tissue harvest.
Development and Validation of a Novel Anaerobic Carbapenem Inactivation Method (Ana-CIM) for the Detection of Carbapenemase Production in Bacteroides fragilis
Eberly, Allison R. , Wallace, Meghan A. , Shannon, Samantha, Heitman, Angela K., Schuetz, Audrey N. , Burnham, Carey‐Ann D. , Jean, Sophonie , Schuetz, Audrey N , Burnham, C A , Eberly, Allison R

Mayo Clinic

Journal of Clinical Microbiology | March 22, 2022 | Volume: 60 | Issue: 4 | Pages: No page available

10.1128/jcm.02188-21 | PMID 35313739 Get It

Antibiotic resistance, particularly to carbapenems, is of increasing concern in Bacteroides fragilis . Carbapenem resistance in B. fragilis is most often mediated by the activation of chromosomally encoded metallo-β-lactamase cfiA by the presence of an upstream insertion sequence (IS).
Quality of life metrics in LVAD patients after hemocompatibility‐related adverse events
Weber, Matthew P. , Stulak, John M., Maltais, Simon, Tchantchaleishvili, Vakhtang , Weber, Matthew P , Pagani, Francis D. , Cowger, Jennifer , Tchantchaleishvili, Vakhtang

Mayo Clinic

Artificial Organs | March 22, 2022 | Volume: 46 | Issue: 8 | Pages: 1616-1625

10.1111/aor.14235 | PMID 35315092 Get It

Abstract Background Hemocompatibility‐related adverse events (HRAE) negatively influence survival. However, no study has examined the impact of these events on health‐related quality of life (HRQOL) and functional outcomes following continuous‐flow left ventricular assist device implantation (CF‐LVAD). We assessed the impact of HRAE events on HRQOL and hypothesized that HRAE's adversely impact HRQOL and functional outcomes. Methods INTERMACS database identified patients undergoing primary CF‐LVAD implantation from 2008 to 2017. HRAEs included stroke, non‐surgical bleeding, hemolysis, and pump thrombosis and were identified as defined in the literature. HRAEs were further stratified as Tier 1–2 and disabling stroke events. Time‐series analysis was executed for HRAE patients with values pre‐HRAE, post‐HRAE, and closest to 12 months follow up. Local polynomial regression curves modeling individual patients were superimposed into “spaghetti” plots. Results All HRQOL and functional metrics improved in patients over time, despite HRAE complications. However, these patient metrics were significantly reduced compared to the non‐HRAE cohort. Advanced data visualization techniques noted a decline after experiencing an HRAE with a subsequent recovery to baseline levels or higher. Six‐minute walk test (6MWT) was noted to be most affected in the post‐HRAE period but recovered similar to other metrics. Conclusions The burden of HRAE following CF‐LVAD implantation did not negatively impact the quality of life. However, the 6MWT did not increase in the post‐HRAE period in all HRAE patients. Improvement of heart failure symptoms after CF‐LVAD coupled with optimal management following the HRAE act to preserve the enhanced quality of life.
Surgery for aortic recoarctation in children less than 10 years old: A single‐center experience in Siberia, Russia
Egunov, O.A. , Кривощеков, Е. В. , Cetta, Frank , Aa, Sokolov , Sviazov, Evgenii A. , Shipulin, V. V. , Egunov, Oleg A , Krivoshchekov, Evgeny V , Sokolov, Alexander A , Shipulin, Vladimir V

Mayo Clinic

Journal of Cardiac Surgery | March 22, 2022 | Volume: 37 | Issue: 6 | Pages: 1627-1632

10.1111/jocs.16435 | PMID 35315136 Get It

“Novel Management of Depression Using Ketamine in the Intensive Care Unit”
Giri, Abhishek R. , Kaur, Nirmaljot , Yarrarapu, Siva Naga S. , Pietrzak, Kathleen A. Rottman, Santos, Christan D. , Lowman, Philip, Niaz, Shehzad, Sanghavi, Devang , Rottman Pietrzak, Kathleen A, Santos, Christan, Lowman, Philip E, Sanghavi, Devang K., Yarrarapu, Siva Naga S , Giri, Abhishek R , Kaur, Nirmaljot , Franco, Pablo Moreno

Mayo Clinic

Journal of Intensive Care Medicine | March 22, 2022 | Volume: 37 | Issue: 12 | Pages: 1654-1661

10.1177/08850666221088220 | PMID 35313768 Get It

Background: Ketamine, a dissociative anesthetic, induces improvement in depressive symptoms by antagonizing glutaminergic NMDA receptors. Ketamine has been used previously in outpatient setting for treatment-resistant depression, but we showcase its utility in depression management at the Intensive Care Unit (ICU). Research Question: Can ketamine be used for depression treatment in ICU patients? Study Design and Methods: A retrospective chart review of ICU patients was done at a tertiary center from 2018 to 2021, to assess the ketamine usage. Among the patients reviewed, ketamine was used for depression in 12, and for analgesia & sedation in 2322 patients. Ketamine was administered in doses of 0.5mg/kg & 0.75mg/kg for depression. Each course consisted of 3 doses of ketamine administered over 3 days, and 7 in 12 patients received a single course of ketamine. The rest received 3–4 courses 1 week apart. Results: Ketamine was found to improve mood and affect in most of the patients with depression. 11 in 12 patients had a positive response with better sleep. It has a major advantage over conventional anti-depressants since it takes only a few hours to induce clinical improvement. Patients who were observably withdrawn from care team and family, were administered ketamine. Conclusion: A major drawback of ketamine is that the duration of clinical improvement is short, with the response lasting only up to seven days after a single dose. Hence, all the patients in our study were weaned off ketamine with a supporting antidepressant. Ketamine has been documented to cause cardio-neurotoxicity; however, only one patient had worsening lethargy in our study. To conclude, ketamine has a marked benefit in treating depression in the ICU. Although our study was associated with positive outcomes, there is a need for prospective studies with long-term follow-up assessments.
Characterizing Amyloid-Positive Individuals With Normal Tau PET Levels After 5 Years
Josephs, Keith A. , Weigand, Stephen D. , Whitwell, Jennifer L. , Whitwell, Jennifer L.

Mayo Clinic

Neurology | March 21, 2022 | Volume: 98 | Issue: 22 | Pages: No page available

10.1212/wnl.0000000000200287 | PMID 35314506 Get It

Clinicopathologic Factors Associated With Reversion to Normal Cognition in Patients With Mild Cognitive Impairment
Li, Zonghua , Kanekiyo, Takahisa , Martens, Yuka A. , Day, Gregory S. , Vassilaki, Maria , Liu, Chia‐Chen , Bennett, David A. , Petersen, Ronald C. , Zhao, Na , Kanekiyo, Takahisa , Atagi, Yuka , Day, Gregory S , Vassilaki, Maria , Liu, Chia-Chen , Bennett, David A. , Petersen, Ronald C , Zhao, Na , Bu, Guojun , Li, Zonghua , Heckman, Michael G. , Bu, Guojun

Mayo Clinic

Neurology | March 21, 2022 | Volume: 98 | Issue: 20 | Pages: No page available

10.1212/wnl.0000000000200387 | PMID 35314499 Get It

Update to “Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors”
Zhu, Mojun , Bekaii‐Saab, Tanios , Bekaii-Saab, Tanios S

Mayo Clinic

The Oncologist | March 21, 2022 | Volume: 27 | Issue: 6 | Pages: e534-e535

10.1093/oncolo/oyac068 | PMID 35403684 Get It

This letter to the editor reports subsequent rechallenge with peptide receptor radionuclide therapy (PRRT) in a patient with pancreatic neuroendocrine tumor bearing BRCA1 mutation previously treated with PRRT.
Social Media and Professional Development for Oncology Professionals
Chidharla, Anusha , Attai, Deanna J. , Drake, Emily K. , Londen, G. J. van , Subbiah, Ishwaria M. , Henry, Elizabeth , Murphy, Martina, Barry, Maura , Manochakian, Rami , Leyfman, Yan , Utengen, Audun , Attai, Deanna J , Drake, Emily K , van Londen, G J , Subbiah, Ishwaria M , Henry, Elizabeth , Barry, Maura M , Manochakian, Rami , Moerdler, Scott , Loeb, Stacy , Graff, Stephanie L , Leyfman, Yan , Thompson, Michael A , Markham, Merry J , Utengen, Audun , Loeb, Stacy , Graff, Stephanie L. , Thompson, Michael A, Markham, Merry Jennifer

Mayo Clinic

JCO Oncology Practice | March 21, 2022 | Volume: 18 | Issue: 8 | Pages: 566-571

10.1200/op.21.00761 | PMID 35312343 Get It

The use of social media continues to increase in health care and academia. Health care practice, particularly the oncologic field, is constantly changing because of new knowledge, evidence-based research, clinical trials, and government policies. Therefore, oncology trainees and professionals continue to strive to stay up-to-date with practice guidelines, research, and skills. Although social media as an educational and professional development tool is no longer completely new to medicine and has been embraced, it is still under-researched in terms of various outcomes. Social media plays several key roles in professional development and academic advancement. We reviewed the literature to evaluate how social media can be used for professional development and academic promotion of oncology professionals.
Patient-specific deep learning model to enhance 4D-CBCT image for radiomics analysis
Zhang, Zeyu , Huang, Mi , Jiang, Zhuoran , Chang, Yushi , Lü, Ke , Yin, F , Tran, Phuoc , Wu, Dapeng , Beltran, Chris , Ren, Lei , Beltran, Chris J

Mayo Clinic

Physics in Medicine & Biology | March 21, 2022 | Volume: 67 | Issue: 8 | Pages: 085003

10.1088/1361-6560/ac5f6e | PMID 35313293 Get It

Abstract Objective. 4D-CBCT provides phase-resolved images valuable for radiomics analysis for outcome prediction throughout treatment courses. However, 4D-CBCT suffers from streak artifacts caused by under-sampling, which severely degrades the accuracy of radiomic features. Previously we developed group-patient-trained deep learning methods to enhance the 4D-CBCT quality for radiomics analysis, which was not optimized for individual patients. In this study, a patient-specific model was developed to further improve the accuracy of 4D-CBCT based radiomics analysis for individual patients. Approach. This patient-specific model was trained with intra-patient data. Specifically, patient planning 4D-CT was augmented through image translation, rotation, and deformation to generate 305 CT volumes from 10 volumes to simulate possible patient positions during the onboard image acquisition. 72 projections were simulated from 4D-CT for each phase and were used to reconstruct 4D-CBCT using FDK back-projection algorithm. The patient-specific model was trained using these 305 paired sets of patient-specific 4D-CT and 4D-CBCT data to enhance the 4D-CBCT image to match with 4D-CT images as ground truth. For model testing, 4D-CBCT were simulated from a separate set of 4D-CT scan images acquired from the same patient and were then enhanced by this patient-specific model. Radiomics features were then extracted from the testing 4D-CT, 4D-CBCT, and enhanced 4D-CBCT image sets for comparison. The patient-specific model was tested using 4 lung-SBRT patients’ data and compared with the performance of the group-based model. The impact of model dimensionality, region of interest (ROI) selection, and loss function on the model accuracy was also investigated. Main results. Compared with a group-based model, the patient-specific training model further improved the accuracy of radiomic features, especially for features with large errors in the group-based model. For example, the 3D whole-body and ROI loss-based patient-specific model reduces the errors of the first-order median feature by 83.67%, the wavelet LLL feature maximum by 91.98%, and the wavelet HLL skewness feature by 15.0% on average for the four patients tested. In addition, the patient-specific models with different dimensionality (2D versus 3D) or loss functions (L1 versus L1 + VGG + GAN) achieved comparable results for improving the radiomics accuracy. Using whole-body or whole-body+ROI L1 loss for the model achieved better results than using the ROI L1 loss alone as the loss function. Significance. This study demonstrated that the patient-specific model is more effective than the group-based model on improving the accuracy of the 4D-CBCT radiomic features analysis, which could potentially improve the precision for outcome prediction in radiotherapy.